Globe Life Earnings Call Highlights Resilient Growth

Globe Life Inc. ((GL)) has held its Q4 earnings call. Read on for the main highlights of the call.

Globe Life Earnings Call Signals Solid Growth Amid Manageable Headwinds

Management at Globe Life Inc. struck a confident tone on the latest earnings call, emphasizing robust premium growth, expanding underwriting margins, strong agency sales, and a rising earnings trajectory into 2026. While they acknowledged operational challenges such as higher agent turnover, elevated lapses in certain channels, compressed excess investment income, and some health-margin pressure, the overall message was one of durable momentum. Strategic capital deployment, particularly share repurchases and a new Bermuda reinsurance structure, reinforced management’s view that shareholder value creation is set to continue despite market-driven unrealized losses and pockets of volatility.

Strong Quarterly and Full-Year Earnings Performance

Globe Life delivered another quarter of earnings growth, underscoring the resilience of its protection-focused business model. Fourth-quarter net income rose to $266 million, or $3.29 per share, from $255 million ($3.01 per share) a year earlier. Net operating income for the quarter reached $274 million, or $3.39 per share, up 8% from $3.14 in the prior-year quarter, showing solid underlying profitability separate from investment and one-time items. For the full year, net operating EPS came in at $14.52, edging above the prior midpoint of guidance. The company’s ability to slightly beat its own full-year expectations, even with investment income headwinds, helped underpin the constructive tone of the call.

Premium Growth and Upbeat 2026 Outlook

Top-line momentum remained healthy, with total premium revenue up 5% year over year in the fourth quarter. Management is even more optimistic looking ahead, calling for total premium revenue growth of roughly 7%–8% in 2026. Within that, life premium growth is projected at 4%–4.5%, while health premiums are expected to expand at a much faster 14%–16% pace. This mix reflects both sustained demand for life insurance products and outsized growth in health-related lines, particularly Medicare Supplement. The guidance signals confidence that Globe Life’s franchise can continue to generate mid- to high-single-digit premium growth despite macroeconomic uncertainty.

Improving Health and Life Underwriting Margins

Core profitability in both life and health lines improved in the quarter. Life underwriting margin reached $350 million in Q4, up 4% from a year ago, while health underwriting margin rose 9% to $99 million. On a normalized full-year basis, the life underwriting margin improved to 41.0% of premium from 39.7%, a meaningful gain that speaks to sound pricing and underwriting discipline. These stronger margins helped offset some pressure in health, where management highlighted claim trends and timing of rate actions. Even so, the company’s ability to expand margins in its largest segment is a key support for the earnings outlook.

Agency Distribution Engines Continue to Deliver

Globe Life’s core agency channels remained a major growth driver. At American Income, life premiums rose 6% to $457 million, while life underwriting margin increased 5% to $208 million. Net life sales at this unit climbed 10% to $102 million, confirming strong new-business momentum. Liberty National also posted solid gains, with life premiums up 4% and net life sales up 6%. Family Heritage stood out on the health side, generating a 10% increase in health premiums and a robust 15% rise in net health sales, supported by an 8% increase in average producing agents. Collectively, these figures underscore that the company’s face-to-face agency network continues to produce steady, profitable growth.

Direct-to-Consumer Channel Achieves Turnaround

One of the more encouraging developments was the continued turnaround in Globe Life’s direct-to-consumer (DTC) business. While DTC life premiums were roughly flat year over year at $244 million, the life underwriting margin improved 3% to $74 million, signaling better economics even without top-line expansion. More notably, net life sales in the segment jumped 24% to $29 million, driven by new technology that has enhanced online conversion and lead-sharing with the agency system. The DTC channel, long challenged by higher lapses and acquisition costs, now appears to be regaining traction and could become a more meaningful contributor to growth if this trend continues.

United American Medicare Supplement Fuels Health Growth

United American, Globe Life’s Medicare Supplement-focused unit, was a standout in the health portfolio. Health premiums increased 14% to $173 million, while net health sales surged to $77 million, roughly $47 million higher than the prior year. The strength was driven by a shift in some policyholders from Medicare Advantage products back to traditional Medicare with supplemental coverage, coupled with premium rate increases approved in multiple states. This combination of volume growth and pricing power has made United American a key driver of the company’s double-digit health premium growth, even as management warns that such exceptional growth rates are unlikely to persist indefinitely.

Investment Portfolio Positioned for Higher Future Yield

On the asset side, Globe Life manages $21.7 billion of invested assets, including $18.8 billion in fixed maturities. The fourth-quarter fixed-maturity yield was 5.29%, up modestly year over year, but the more important story is the yield on new investments: recent purchases have averaged around 6.23%. Management expects the blended earned yield to rise to roughly 5.4%–5.5% in 2026, as higher-yielding new investments gradually replace older, lower-yielding securities. The company plans $900 million–$1.1 billion of fixed-maturity purchases and an additional $300 million–$400 million in commercial mortgages and partnerships, targeting 7%–9% cash returns in these alternative assets. This incremental yield uplift is expected to support earnings, even though near-term net investment income growth remains modest.

Shareholder Returns Supported by Strong Parent Cash Flow

Globe Life continued to prioritize capital returns, highlighting its shareholder-friendly posture. In the fourth quarter, the company repurchased 1.3 million shares for approximately $170 million, bringing full-year repurchases to 5.4 million shares totaling $685 million. Including dividends of about $85 million, the company returned roughly $770 million to shareholders over the year. Parent company excess cash flow was about $620 million in 2025 and is projected to rise to $625 million–$675 million in 2026. Management plans to deploy this toward $85 million–$90 million of dividends and $535 million–$585 million of share repurchases next year, reinforcing the expectation of continued buyback-driven EPS accretion.

Capital Strength and Bermuda Reinsurance Strategy

The company continues to target a consolidated risk-based capital (RBC) ratio in the 300%–320% range, a level management views as appropriate for its risk profile. A major strategic development is the formation of Globe Life Re Ltd. in Bermuda and the execution of an initial reinsurance transaction transferring about $1.2 billion of statutory reserves. This Bermuda reinsurance platform is designed to free up capital and increase parent-level excess cash flow over time, potentially by about $200 million annually in the long run. While these incremental cash flow benefits are not yet reflected in the 2026 guidance, the initiative provides a structural lever for future capital flexibility and enhanced shareholder distributions, subject to regulatory approvals.

Managing Higher Agent Turnover at American Income

Not everything is running smoothly, and management was candid about challenges at American Income, where average producing agent count declined 2% to 11,699 in the quarter. The primary issue is higher-than-expected agent turnover, which can pressure both sales growth and productivity in the near term. Management is rolling out retention initiatives aimed at improving agent engagement and tenure, while emphasizing that production per agent remains solid. Investors will be watching to see whether these measures stabilize the field force, as sustained growth at American Income is a key pillar of the company’s long-term sales strategy.

Elevated Lapses in DTC and Liberty National

Another watch point is policy persistency, particularly in the internet-driven DTC channel and at Liberty National. First-year lapses ticked higher in these segments, reflecting both the inherently more volatile nature of online-acquired customers and normal fluctuation in lapse behavior. Management stated that they currently view the lapse uptick as within expected variability but are monitoring the trend closely. Historically, internet-originated policies tend to exhibit higher early lapses than agent-sold policies, so the key question is whether improved underwriting, targeting, and customer onboarding can mitigate these patterns over time.

Investment Income Pressures and Lower Excess Investment Income

Despite a constructive long-term yield outlook, investment income was a mild drag in the quarter. Net investment income came in at $281 million, essentially flat year over year, and excess investment income fell to $31 million, down roughly $8 million. Several factors weighed on results: slower growth in average invested assets, lower yields on certain short-term commercial mortgage and partnership holdings, and higher cash balances tied to the Bermuda reinsurance transactions. While management expects net investment income to grow modestly going forward, they signaled that excess investment income is likely to remain relatively flat in the near term, limiting its contribution to EPS growth.

Unrealized Bond Losses Reflect Higher Rates, Not Credit Stress

Globe Life’s fixed-maturity portfolio is currently in a net unrealized loss position of about $1.2 billion, driven primarily by higher market interest rates relative to the portfolio’s book yield. Management emphasized that they intend to hold these securities to maturity and are not concerned about credit quality, framing the losses as a mark-to-market accounting impact rather than an economic impairment. While this unrealized deficit is important for investors tracking book value, the hold-to-maturity strategy and strong RBC ratio suggest that the company has the balance-sheet capacity to ride out rate volatility without forced sales.

Health Margin Volatility and United American Normalization

Health margins have shown more volatility and some normalization after very strong performance in prior years. The normalized health underwriting margin for full-year 2025 declined to 25.4% from 27.3%, reflecting higher claims experience and the lag between rising medical costs and the implementation of premium rate increases at United American. Management also guided that first-quarter 2026 health margins will be lower due to seasonally high claims and the phased-in nature of rate hikes. Additionally, after nearly doubling sales in 2025, United American expects flat sales in 2026 as the Medicare marketplace remains uncertain and growth normalizes. While this tempers the near-term growth story in health, the unit still provides a strong base of recurring premium with improving pricing power.

Parent Liquidity Relies on Subsidiary Dividends

The call also highlighted the importance of subsidiary dividends for parent-company liquidity. Parent liquid assets declined from about $90 million at the beginning of the year to around $80 million at year-end 2025 and are projected to be $50 million–$60 million at the end of 2026. Excess cash flow at the parent level is heavily dependent on dividends from operating subsidiaries and on regulatory approvals that will allow full realization of the benefits from the Bermuda reinsurance structure. While management expressed confidence in maintaining adequate liquidity and capital ratios, investors should recognize that parent cash is actively managed and closely tied to the regulatory environment.

Guidance Points to Sustained EPS and Premium Growth

Looking ahead, management guided 2026 net operating earnings per diluted share to a range of $14.95–$15.65, implying about 5% growth at the midpoint and roughly 10% growth on a normalized basis once temporary items are stripped out. Total premium revenue is expected to increase 7%–8%, with life premiums rising 4%–4.5% and health premiums climbing a robust 14%–16%. Life underwriting margins are forecast at 41.5%–44.5%, including an anticipated assumption remeasurement gain in the third quarter that could temporarily lift life margins toward 48%–52%, while health margins are projected in the 23%–27% range. On the investment side, the company expects net investment income to grow 3%–4%, with fixed-maturity yields around 5.3% and a blended earned yield of 5.4%–5.5%. Capital plans include parent excess cash flow of $625 million–$675 million, shareholder distributions of $85 million–$90 million in dividends and $535 million–$585 million in buybacks, year-end parent liquid assets of $50 million–$60 million, and a maintained RBC target of 300%–320%. Notably, potential incremental cash flow from the Bermuda reinsurance platform over time is not yet embedded in this guidance, providing a possible upside lever longer term.

In sum, Globe Life’s earnings call painted a picture of a company balancing solid growth and capital returns with a realistic view of its challenges. Premiums and underwriting margins are moving in the right direction, key distribution channels remain productive, and buybacks continue to support per-share results. At the same time, management is actively addressing agent turnover, lapse trends, and health-margin volatility, while navigating a higher-rate environment that pressures bond valuations and excess investment income. For investors, the overall message is that Globe Life is executing well on its core strategy, with supportive guidance and strategic capital initiatives that could underpin shareholder value in the years ahead.